PHS
ACHC icon

PFM Health Sciences’s Acadia Healthcare ACHC Stock Holding History

PFM Health Sciences’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Sell
524,934
-57,811
-10% -$1.48M 1.33% 26
2026
Q1 		$13.6M Buy
+582,745
New +$10.5M 1.24% 25
2024
Q4 		– Sell
-686,150
Closed -$43.5M – 84
2024
Q3 		$43.5M Buy
686,150
+265,986
+63% +$19.2M 2.47% 13
2024
Q2 		$28.4M Buy
420,164
+152,430
+57% +$10.6M 1.4% 26
2024
Q1 		$21.2M Sell
267,734
-40,203
-13% -$3.29M 1% 35
2023
Q4 		$23.9M Sell
307,937
-69,932
-19% -$5.18M 1.44% 25
2023
Q3 		$26.6M Sell
377,869
-3,433
-0.9% -$257K 1.25% 35
2023
Q2 		$30.4M Buy
381,302
+70,367
+23% +$5.09M 1.18% 37
2023
Q1 		$22.5M Buy
+310,935
New +$24.2M 0.99% 41
2016
Q2 		– Sell
-130,817
Closed -$7.21M – 80
2016
Q1 		$7.21M Buy
+130,817
New +$7.47M 0.22% 72
2015
Q3 		– Sell
-227,174
Closed -$17.8M – 77
2015
Q2 		$17.8M Buy
+227,174
New +$16.4M 0.45% 60

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

PFM Health Sciences's ACHC Position: Q2 2026 in Review

PFM Health Sciences reduced its Acadia Healthcare (ACHC) stake by 9.9% in Q2 2026, selling an estimated $1.48M and leaving 524,934 shares worth $15.5M. The position accounts for 1.33% of the portfolio, ranked #26.

PFM Health Sciences first reported a position in ACHC in Q2 2015 and has held it in 11 quarters since. The position peaked at $43.5M in Q3 2024. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • PFM Health Sciences held 524,934 shares of Acadia Healthcare worth $15.5M as of Q2 2026.
  • PFM Health Sciences sold 57,811 Acadia Healthcare shares in Q2 2026, an estimated $1.48M.
  • Acadia Healthcare made up 1.33% of PFM Health Sciences's portfolio in Q2 2026, its #26 holding.
  • PFM Health Sciences first reported a position in Acadia Healthcare in Q2 2015 and has held it in 11 quarters since.
  • PFM Health Sciences's Acadia Healthcare position peaked at $43.5M in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.